← Back to all trials
Active Not Recruiting
NCT05056207
PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema
Conditions: Lymphedema
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 260
Sponsor: M.D. Anderson Cancer Center
Location: M D Anderson Cancer Center Houston Texas
Summary
This research study is to learn about breast cancer patients' opinions about screening for lymphedema (a side effect of breast cancer treatment in which the arm can become heavy, painful, and/or swollen) and their satisfaction with the lymphedema screening program.
Eligibility Criteria
Inclusion Criteria:
a Cohort A:
* Breast cancer patients with a baseline (preoperative perometer measurements) who have undergone axillary lymph node dissection
* English speaker
* Patients who participate in Cohort A will be eligible for enrollment in Cohort
b Cohort I:
* Breast cancer patients who have undergone axillary lymph node dissection who have a clinic visit in the Nellie B. Connally Breast Center approximately 12 months (+/- 4 months) following axillary lymph node dissection
* English speaker
c Cohort II:
* Breast cancer patients who have undergone axillary lymph node dissection who are having a follow-up visit in the Nellie B. Connally Breast Center within 0-6 months following surgery who intend to continue follow-up care at MD Anderson
* English speaker
Exclusion Criteria:
Inability to complete a self-administered questionnaire
Source: ClinicalTrials.gov (NCT05056207). StuddyBuddy aggregates publicly available trial information.